NEOGEN Q1 FY26 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹187 Cr
verified against source
Revenue YoY
4%
reported change
EBITDA
₹31.5 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Neogen Chemicals delivered Q1 FY26 consolidated revenue of INR 186.7 crore (+4% YoY) despite the Dahej bromine plant fire keeping it offline throughout the quarter. EBITDA stood at INR 31.5 crore (+2% YoY) with EBITDA margin of 16.9% (consolidated), supported by favorable product mix and cost optimization that offset soft bromine pricing. PAT came in at INR 10.3 crore. NeoGen Ionics contributed INR 5.44 crore in its maiden consolidated quarter. The replacement Dahej plant is on track for next-year commissioning, with INR 268.27 crore net insurance receivable pending. The Morita JV for lithium salt production is in final alignment stage (expected in 2-3 months) and will be a wholly-owned subsidiary. Management maintained FY26 guidance: 825-875 crore for base business and 300 crore for battery chemicals, with majority of battery chemicals revenue expected in H2. Key risks include customer approval delays for lithium salts exports, tariff uncertainty, and timing mismatch on insurance receipts versus capex deployment.
Colored figures show movement against the previous available record.
Guidance to track
- Management reaffirmed base business guidance despite Dahej fire impact, citing volume growth, pharma pickup, and alternate sourcing strategies to offset bromine plant unavailability.
- NeoGen Ionics expected to generate INR 300 crore with majority contribution in H2 FY26 as customer approvals complete and cell manufacturing ramps up at Ola, Exide, and others.
- Management maintained 20% return on capital target for electrolyte and lithium salt business at peak capacity utilization, with current pricing competitive versus Japanese and Korean suppliers.
- Board approved raising INR 200 crore via NCD for liquidity buffer to address potential timing mismatch between ongoing capex and insurance receipts, not for additional growth funding.
Risks flagged
- Key US customer has delayed plant audit scheduling due to ongoing tariff and policy uncertainty. Management is selling limited volumes to non-regulated markets (China) as interim measure while awaiting approvals.
- US tariff policy remains fluid with potential exemptions for battery materials. Management acknowledged difficulty predicting outcomes but noted Japan/Korea/India compete differently than China-based suppliers.
- Dahej bromine capacity expansion to 2,500 MT will require ~15-day shutdown in Q2 FY26 to connect to existing facilities. Timing could affect agro segment recovery and international customer supplies.
- Analyst questioned loss on profit estimate from fire incident; management deflected stating process only begins post-plant reinstatement, making FY26 impact uncertain. Net receivable of INR 268.27 crore is outstanding with INR 80.55 crore received.
Key quotes
- What we have seen is that with the tariff coming in now there is more clarity and while there is lesser IRA for the battery EV manufacturers there is clarity on the battery and the requirement of non-China. So again customers who were sitting on the fence are now even more keen.
- I request all of you to have a little bit of patience. What we really should be looking at is what is the scenario in 2027-28 when we said we are going to have full utilization levels.
- I think maximum they'll have three supplier approved. Backup would be somewhere on a lower side 10-15%, on the higher side around 25-30%.
Research modules